Individualized treatment strategies and considerations in patients with mild asthma: Discussion of Canadian Thoracic Society guideline recommendations.
| Autor: | Waite ME; Family physician at the Moncton Hospital in New Brunswick., Yang CL; Investigator and Pediatric Respirologist at BC Children's Hospital in Vancouver and Clinical Associate Professor in the Division of Respiratory Medicine and Department of Pediatrics at the University of British Columbia. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Canadian family physician Medecin de famille canadien [Can Fam Physician] 2023 Dec; Vol. 69 (12), pp. 829-832. |
| DOI: | 10.46747/cfp.6912829 |
| Abstrakt: | Objective: To highlight recommendations from the Canadian Thoracic Society (CTS) 2021 asthma guideline for adults and children aged 12 years and older and to address controversies related to the update. Sources of Information: The CTS 2021 asthma guideline. Main Message: Asthma is a common condition encountered in primary care. Poor symptom control and exacerbations contribute substantially to the burden of disease. Practice guidelines have been shifting in recent years toward more aggressive treatment of very mild and mild asthma, with goals of optimizing symptom control and reducing exacerbations. Consider underlying risk of exacerbation, extent of asthma symptoms, adherence levels, and treatment cost when choosing therapy for patients with very mild and mild asthma. Conclusion: The goal of this article is to briefly review the evidence and rationale behind treatment options in the CTS guideline to help physicians make patient-centred decisions. (Copyright © 2023 the College of Family Physicians of Canada.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|